Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06223971 · ClinicalTrials.gov registry record · Early Phase 1

Long COVID-19 [11C]CPPC Study

A Early Phase 1 study of COVID Long-Haul, sponsored by Johns Hopkins University.

Active
Registry status
Early Phase 1
Development phase
6
Enrollment target
1
Study location

NCT06223971: Active Early Phase 1 study of COVID Long-Haul, sponsored by Johns Hopkins University.

NCT06223971 is a Early Phase 1 study of COVID Long-Haul that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 6 participants, below the 214-participant average among 4 other COVID Long-Haul trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06223971, a Early Phase 1 study of COVID Long-Haul, is active but no longer recruiting, sponsored by Johns Hopkins University.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to evaluate the safety of using the \[5-cyano-N-(4-(4-\[11C\]Methylpiperazin-1-yl)-2-(Piperidin-1-yl)Phenyl)Furan-2-carboxamide\] (\[11C\]CPPC) radiotracer in positron emission tomography (PET) imaging of people with history of COVID-19 infection, with and without symptoms. The investigators are also interested to see whether use of this radiotracer reveals imaging differences between patients with history of COVID-19 infection and still exhibiting symptoms or healthy patients with history of COVID-19 infection but exhibiting no current symptoms.

Primary Outcome

Safety and tolerability will be determined by evaluation of spontaneously reported adverse events, clinical laboratory test results, physical, cognitive and neurologic exams and imaging (PET).

Conditions Studied

COVID Long-Haul

Interventions

  • DRUG [11C]CPPC Injection

Study Locations (1)

Maryland

  • Johns Hopkins Outpatient Center - Baltimore

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2024-08-06
Est. Completion 2026-03-31
Phase Early Phase 1
Johns Hopkins University

1,448 total trials

What the registry record for NCT06223971 still lists

NCT06223971 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 214-participant average among 4 other COVID Long-Haul trials with a reported enrollment target (97% lower).

The record links to 1 condition, with COVID Long-Haul appearing as the primary indexed condition, and to 1 intervention - of which [11C]CPPC Injection is the first listed.

NCT06223971 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06223971 about?

NCT06223971 is a clinical study titled "Long COVID-19 [11C]CPPC Study". The goal of this study is to evaluate the safety of using the \[5-cyano-N-(4-(4-\[11C\]Methylpiperazin-1-yl)-2-(Piperidin-1-yl)Phenyl)Furan-2-carboxamide\] (\[11C\]CPPC) radiotracer in positron emission tomography (PET) imaging of people with history of COVID-19 infection, with and without symptoms....

What is the current status of trial NCT06223971?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2024-08-06. Estimated completion is 2026-03-31.

What conditions does trial NCT06223971 study?

This clinical trial studies the following conditions: COVID Long-Haul.

What interventions are being tested in trial NCT06223971?

The interventions under investigation include: [11C]CPPC Injection (DRUG).

Who is sponsoring clinical trial NCT06223971?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06223971 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for COVID Long-Haul

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06223971, the US trial registry maintained by the National Library of Medicine. NCT06223971 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.